Talk:Arbutus Biopharma

This article is rated Stub-class on Wikipedia's content assessment scale.
It is of interest to the following WikiProjects:

Canada Low‑importance

	Canada portal This article is within the scope of WikiProject Canada, a collaborative effort to improve the coverage of Canada on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CanadaWikipedia:WikiProject CanadaTemplate:WikiProject CanadaCanada-related articles
Low	This article has been rated as Low-importance on the project's importance scale.

Companies Low‑importance

This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany articles

Low This article has been rated as Low-importance on the project's importance scale.

WikiProject Companies To-do:

Here are some tasks awaiting attention:

Article requests : Wikipedia:Requested articles/Business and economics/Companies
Assess : Category:Unassessed company articles
Copyedit : Category:Company articles needing attention
Infobox : Category:Company articles needing infoboxes
Maintain : Portal:Companies
Stubs : Help expand stub articles located at Category:Company stubs
Other :
- Tag company articles with the {{portal|Companies}} template
- Tag company talk pages with the {{WikiProject Companies}} project banner
- Answer requests for comments

Medicine Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Low	This article has been rated as Low-importance on the project's importance scale.

Update Request

Roivant recently invested in Arbutus' hepatitis B program. Can you update the page to include information on the program/investment? ^[1] ^[2] ^[3] 68.0.86.218 (talk) 15:04, 8 November 2017 (UTC)[reply]

References

[1] ttps://www.fiercebiotech.com/biotech/ramaswamy-s-roivant-backs-arbutus-hepatitis-b-program

[2] ttp://roivant.com/arbutus-receive-116-million-strategic-investment-roivant-sciences/

[3] ttps://www.forbes.com/sites/nathanvardi/2017/10/02/roivant-makes-116-million-investment-in-arbutus-backing-battle-with-moderna/#30896a865e20

[1]

[2]

[3]